Avidity in antibody effector functions and biotherapeutic drug design
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Avidity in antibody effector functions and biotherapeutic drug design
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-06
DOI
10.1038/s41573-022-00501-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
- (2022) Laura A. VanBlargan et al. NATURE MEDICINE
- Conserved topology of virus glycoepitopes presents novel targets for repurposing HIV antibody 2G12
- (2022) Nathaniel L. Miller et al. Scientific Reports
- The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa
- (2022) Yuki Yamaguchi et al. mAbs
- Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2
- (2022) Emi Takashita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection
- (2021) Myron S. Cohen NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
- (2021) Hope S. Rugo et al. JAMA Oncology
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus
- (2021) Bronwyn M. Gunn et al. IMMUNITY
- Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
- (2021) Joost Neijssen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis
- (2021) Dana L. E. Vergoossen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
- (2021) Dapeng Li et al. CELL
- Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
- (2021) Irfan Ullah et al. IMMUNITY
- On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation
- (2021) Joshua M. Sopp et al. Communications Biology
- New INN nomenclature for monoclonal antibodies
- (2021) Raffaella Balocco et al. LANCET
- Structural and immunogenomic insights into B-cell receptor activation
- (2020) Yangyang Feng et al. Journal of Genetics and Genomics
- Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
- (2020) Lionel Rougé et al. SCIENCE
- Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation
- (2020) Sylwia Jones et al. Scientific Reports
- Multispecific drugs herald a new era of biopharmaceutical innovation
- (2020) Raymond J. Deshaies NATURE
- DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
- (2020) Simone C. Oostindie et al. Blood Cancer Journal
- Amivantamab (JNJ-61186372), An Fc Enhanced EGFR/cMet Bispecific Antibody Induces Receptor Downmodulation And Anti-tumor Activity By Monocyte/Macrophage Trogocytosis
- (2020) Smruthi Vijayaraghavan et al. MOLECULAR CANCER THERAPEUTICS
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
- (2020) Johanna Hansen et al. SCIENCE
- Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism
- (2020) Marije B. Overdijk et al. MOLECULAR CANCER THERAPEUTICS
- Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
- (2020) Stylianos Bournazos et al. NATURE
- Binding mechanisms of therapeutic antibodies to human CD20
- (2020) Anand Kumar et al. SCIENCE
- REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
- (2020) Alina Baum et al. SCIENCE
- A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms
- (2020) James E. Stefano et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- (2020) Alexandra Schäfer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
- (2019) Anna Z. Wec et al. Cell Host & Microbe
- Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions
- (2019) Pablo Carravilla et al. Nature Communications
- Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
- (2019) Thomas A Ollila et al. OncoTargets and Therapy
- CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
- (2019) Simone C. Oostindie et al. HAEMATOLOGICA
- Considerations for the Design of Antibody-Based Therapeutics
- (2019) Dennis R. Goulet et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Tetravalent biepitopic targeting enables intrinsic antibody agonism of tumor necrosis factor receptor superfamily members
- (2019) Yanli Yang et al. mAbs
- Unraveling the Macromolecular Pathways of IgG Oligomerization and Complement Activation on Antigenic Surfaces
- (2019) Jürgen Strasser et al. NANO LETTERS
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b
- (2019) Thomas H. Sharp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Neonatal Fc Receptor (FcRn): A Misnomer?
- (2019) Michal Pyzik et al. Frontiers in Immunology
- Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
- (2019) Arianne M. Brandsma et al. Frontiers in Immunology
- HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality
- (2019) David M. Richards et al. Journal for ImmunoTherapy of Cancer
- IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a Fc-Fc-dependent mechanism
- (2019) Ulrich F. Prodjinotho et al. PARASITOLOGY RESEARCH
- Concepts for agonistic targeting of CD40 in immuno-oncology
- (2019) David M. Richards et al. Human Vaccines & Immunotherapeutics
- Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors
- (2019) Dennis R. Goulet et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Weak Fragment Crystallizable (Fc) Domain Interactions Drive the Dynamic Assembly of IgG Oligomers upon Antigen Recognition
- (2019) Jürgen Strasser et al. ACS Nano
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
- (2018) Kristen E Pascal et al. JOURNAL OF INFECTIOUS DISEASES
- Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement
- (2018) Deniz Ugurlar et al. SCIENCE
- Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope
- (2018) Katharina Imkeller et al. SCIENCE
- Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
- (2018) James J. Steinhardt et al. Nature Communications
- Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis
- (2018) Hanke L. Matlung et al. Cell Reports
- Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways
- (2018) Gina-Maria Lilienthal et al. Frontiers in Immunology
- Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
- (2018) Clara Montagut et al. JAMA Oncology
- A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer
- (2018) Gururaj Shivange et al. CANCER CELL
- Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets
- (2018) Maaike Rijkers et al. HAEMATOLOGICA
- Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
- (2018) Sijia Huang et al. mAbs
- A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity
- (2018) Meinolf Thiemann et al. Frontiers in Oncology
- Redirected T Cell Cytotoxicity in Cancer Therapy
- (2018) Raphael A. Clynes et al. Annual Review of Medicine
- The immune response against flaviviruses
- (2018) Jose Luis Slon Campos et al. NATURE IMMUNOLOGY
- CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells
- (2018) Kerstin Schütze et al. Frontiers in Immunology
- CD32 Ligation Promotes the Activation of CD4+ T Cells
- (2018) María Pía Holgado et al. Frontiers in Immunology
- The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein
- (2018) Emiri Hiramoto et al. Science Advances
- Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts
- (2018) David Oyen et al. Science Advances
- Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells
- (2017) Annalina Tammen et al. JOURNAL OF IMMUNOLOGY
- Functional optimization of agonistic antibodies to OX40 receptor with novel Fc mutations to promote antibody multimerization
- (2017) Di Zhang et al. mAbs
- IgG cooperativity – Is there allostery? Implications for antibody functions and therapeutic antibody development
- (2017) Danlin Yang et al. mAbs
- Simultaneous Targeting of Two Distinct Epitopes on MET Effectively Inhibits MET- and HGF-Driven Tumor Growth by Multiple Mechanisms
- (2017) Michael M. Grandal et al. MOLECULAR CANCER THERAPEUTICS
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface
- (2017) T. E. Michaelsen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
- (2017) Ling Xu et al. SCIENCE
- IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
- (2017) Taia T. Wang et al. SCIENCE
- Structural basis of a novel heterodimeric Fc for bispecific antibody production
- (2017) Hudie Wei et al. Oncotarget
- Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
- (2017) Haipeng Liu et al. Scientific Reports
- A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies
- (2016) Kensei Tobinai et al. ADVANCES IN THERAPY
- Onto better TRAILs for cancer treatment
- (2016) D de Miguel et al. CELL DEATH AND DIFFERENTIATION
- The First-in-class Anti-EGFR Antibody Mixture Sym004 Overcomes Cetuximab Resistance Mediated by EGFR Extracellular Domain Mutations in Colorectal Cancer
- (2016) F. J. Sanchez-Martin et al. CLINICAL CANCER RESEARCH
- Harnessing Fc receptor biology in the design of therapeutic antibodies
- (2016) Peter Sondermann et al. CURRENT OPINION IN IMMUNOLOGY
- Editorial overview: Special section: New concepts in antibody therapeutics: What's in store for antibody therapy?
- (2016) Janine Schuurman et al. CURRENT OPINION IN IMMUNOLOGY
- Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody
- (2016) Di Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Modeling and Experimental Investigation of the Effects of Antigen Density, Binding Affinity, and Antigen Expression Ratio on Bispecific Antibody Binding to Cell Surface Targets
- (2016) John J. Rhoden et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CSF-1R–Dependent Lethal Hepatotoxicity When Agonistic CD40 Antibody Is Given before but Not after Chemotherapy
- (2016) Katelyn T. Byrne et al. JOURNAL OF IMMUNOLOGY
- Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions
- (2016) Erika M. Cook et al. JOURNAL OF IMMUNOLOGY
- Cross-arm binding efficiency of an EGFR x c-Met bispecific antibody
- (2016) Songmao Zheng et al. mAbs
- Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells
- (2016) Katharine D. Grugan et al. mAbs
- Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen
- (2016) Guanbo Wang et al. MOLECULAR CELL
- Control of B Cell Responsiveness by Isotype and Structural Elements of the Antigen Receptor
- (2016) Elias Hobeika et al. TRENDS IN IMMUNOLOGY
- A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
- (2016) Rob N. de Jong et al. PLOS BIOLOGY
- TRAIL-receptor 1 IgM antibodies strongly induce apoptosis in human cancer cellsin vitroandin vivo
- (2016) Xiuhong Piao et al. OncoImmunology
- Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen
- (2016) Yariv Mazor et al. PLoS One
- Phagocytosis of immunoglobulin-coated emulsion droplets
- (2015) Kalthoum Ben M'Barek et al. BIOMATERIALS
- Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor
- (2015) Kyriakos P. Papadopoulos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect
- (2015) David J. DiLillo et al. CELL
- Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
- (2015) H. J. Jacobsen et al. CLINICAL CANCER RESEARCH
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- A single glycan on IgE is indispensable for initiation of anaphylaxis
- (2015) Kai-Ting C. Shade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering
- (2015) Yuki Iwayanagi et al. JOURNAL OF IMMUNOLOGY
- Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease
- (2015) Xiaoyu Zhang et al. JOURNAL OF IMMUNOLOGY
- IgA as therapeutic antibody
- (2015) Jeanette H.W. Leusen MOLECULAR IMMUNOLOGY
- Complement in therapy and disease
- (2015) Joost P.M. Melis et al. MOLECULAR IMMUNOLOGY
- Responsiveness of B cells is regulated by the hinge region of IgD
- (2015) Rudolf Übelhart et al. NATURE IMMUNOLOGY
- Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
- (2014) Stylianos Bournazos et al. CELL
- Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
- (2014) Saskia Meyer et al. mAbs
- Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
- (2014) C. A. Diebolder et al. SCIENCE
- IgGs are made for walking on bacterial and viral surfaces
- (2014) Johannes Preiner et al. Nature Communications
- Affinity Enhancement of Antibodies: How Low-Affinity Antibodies Produced Early in Immune Responses Are Followed by High-Affinity Antibodies Later and in Memory B-Cell Responses
- (2014) H. N. Eisen Cancer Immunology Research
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
- (2013) R. Kapur et al. BLOOD
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer
- (2013) Ajay Jain et al. EUROPEAN JOURNAL OF CANCER
- Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant
- (2013) Futa Mimoto et al. mAbs
- Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies
- (2013) Brian D. Harms et al. METHODS
- APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fc Receptors
- (2013) C. Gieffers et al. MOLECULAR CANCER THERAPEUTICS
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) A. F. Labrijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation
- (2013) R. Muller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Engineered antibody Fc variant with selectively enhanced Fc RIIb binding over both Fc RIIaR131 and Fc RIIaH131
- (2013) F. Mimoto et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Neutrophils as effector cells for antibody-based immunotherapy of cancer
- (2013) Marjolein van Egmond et al. SEMINARS IN CANCER BIOLOGY
- Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12
- (2013) Yunji Wu et al. Cell Reports
- Back to the future: recombinant polyclonal antibody therapeutics
- (2013) Xian-zhe Wang et al. Current Opinion in Chemical Engineering
- On the roles of polyvalent binding in immune recognition: Perspectives in the nanoscience of immunology and the immune response to nanomedicines
- (2012) Thomas Vorup-Jensen ADVANCED DRUG DELIVERY REVIEWS
- Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells
- (2012) Marielle A. Otten et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- B-cell receptor: from resting state to activate
- (2012) Bebhinn Treanor IMMUNOLOGY
- Exhaustion of Cytotoxic Effector Systems May Limit Monoclonal Antibody-Based Immunotherapy in Cancer Patients
- (2012) F. J. Beurskens et al. JOURNAL OF IMMUNOLOGY
- Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fc receptor engagement
- (2012) F. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies
- (2011) W. Alduaij et al. BLOOD
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- (2011) Nicholas S. Wilson et al. CANCER CELL
- Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII)
- (2011) Katja Klausz et al. CANCER SCIENCE
- Benralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthma
- (2011) Aasia Ghazi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
- (2011) Holly M. Horton et al. JOURNAL OF IMMUNOLOGY
- Species-Specific Determinants in the IgG CH3 Domain Enable Fab-Arm Exchange by Affecting the Noncovalent CH3-CH3 Interaction Strength
- (2011) A. F. Labrijn et al. JOURNAL OF IMMUNOLOGY
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- Functional Characteristics of the High Affinity IgG Receptor, Fc RI
- (2011) C. E. van der Poel et al. JOURNAL OF IMMUNOLOGY
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
- (2011) C. Ferrara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting
- (2010) Markus Kügler et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sym004: A Novel Synergistic Anti-Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy
- (2010) M. W. Pedersen et al. CANCER RESEARCH
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
- (2010) Roland Kolbeck et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Very Few Substitutions in a Germ Line Antibody Are Required To Initiate Significant Domain Exchange
- (2010) Michael Huber et al. JOURNAL OF VIROLOGY
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
- (2010) Hugo Mouquet et al. NATURE
- CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
- (2010) Stephen A. Beers et al. SEMINARS IN HEMATOLOGY
- Few and Far Between: How HIV May Be Evading Antibody Avidity
- (2010) Joshua S. Klein et al. PLoS Pathogens
- Affinity and Avidity in Antibody-Based Tumor Targeting
- (2009) Stephen I. Rudnick et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity
- (2009) Akito Natsume et al. CANCER SCIENCE
- Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
- (2009) J. S. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Difference in the Complement Activation Site of Human IgG1 and IgG3
- (2009) T. E. Michaelsen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities
- (2008) A. Natsume et al. CANCER RESEARCH
- Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
- (2008) M. Dechant et al. CANCER RESEARCH
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
- Optimization of antibody binding to Fc RIIa enhances macrophage phagocytosis of tumor cells
- (2008) J. O. Richards et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
- (2008) Seung Y. Chu et al. MOLECULAR IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now